我院2013-2015年门急诊氨酚羟考酮使用情况分析
x

请在关注微信后,向客服人员索取文件

篇名: 我院2013-2015年门急诊氨酚羟考酮使用情况分析
TITLE:
摘要: 目的:为氨酚羟考酮的临床合理使用提供参考。方法:采用回顾性研究方法,对我院2013-2015年门急诊氨酚羟考酮的使用情况进行统计、分析。结果:我院2013-2015年氨酚羟考酮门急诊处方共22 654张,各年度氨酚羟考酮的处方数、用量和销售金额均呈逐年增长趋势。氨酚羟考酮的使用涉及所有临床科室,处方数排前3位的科室分别为骨科(78.34%)、急诊科(15.52%)和肿瘤科(2.09%)。使用氨酚羟考酮的患者年龄集中在19~64岁(78.62%),男女比例为1 ∶ 1.08。氨酚羟考酮用法用量以5 mg、每日4次为主(86.91%)。处方涉及的诊断中,排前3位的分别是骨性关节病(47.26%)、腰腿痛(6.18%)和腹痛待查(5.92%)。结论:我院2013-2015年门急诊氨酚羟考酮用量较大,存在不合理使用现象,需加强管理,规范其使用。
ABSTRACT: OBJECTIVE: To provide reference for rational use of oxycodone and acetaminophen in outpatient and emergency department. METHODS: By retrospective study, the application of oxycodone and acetaminophen in outpatient and emergency department of our hospital during 2013-2015 was analyzed statistically. RESULTS: During 2013-2015, there were 22 654 outpatient and emergency prescriptions of oxycodone and acetaminophen in our hospital. The prescription number, amount and consumption sum of oxycodone and acetaminophen were increasing year by year. Top 3 clinical departments of oxycodone and acetaminophen in the list of prescription number were orthopedics department (78.34%), emergency department (15.52%) and oncology department (2.09%). The age of patients using oxycodone and acetaminophen mainly aged 19-64 years old (78.62%); the ratio of male to female was 1 ∶ 1.08.  The amount of oxycodone and acetaminophen was 5 mg, mainly 4 times a day (86.91%). In all kinds of diagnosis, knee osseous arthritis (47.26%), pain in waist and lower extremities (6.18%) and abdominal pain in dispute (5.92%) were top three. CONCLUSIONS: A large amount of oxycodone and acetaminophen were used in outpatient and emergency department of our hospital during 2013-2015; there is unreasonable drug use so that we need to strengthen management and standardize drug use.
期刊: 2017年第28卷第17期
作者: 牛兰,张凤
AUTHORS: NIU Lan,ZHANG Feng
关键字: 氨酚羟考酮;合理用药;处方分析;门诊;急诊
KEYWORDS: Oxycodone and acetaminophen; Rational drug use; Prescription analysis; Outpatient; Emergency
阅读数: 527 次
本月下载数: 3 次

* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!